MC1R genotype
Showing 1 - 25 of >10,000
Stroke Trial in Laval (Cardiovascular training, Standard Therapy)
Recruiting
- Stroke
- Cardiovascular training
- Standard Therapy
-
Laval, Quebec, CanadaJewish Rehabiliation Hospital
Nov 17, 2022
Skin Cancer Trial in Salt Lake City (Education, Action Plan, UV Photo)
Not yet recruiting
- Skin Cancer
- Education
- +3 more
-
Salt Lake City, UtahHuntsman Cancer Institute
Dec 1, 2022
Healthy Lifestyle, Taste Disorders, Diet Habit Trial in Poznan (Intervention genotype personalized nutritional recommendations,
Completed
- Healthy Lifestyle
- +2 more
- Intervention genotype personalized nutritional recommendations
- +2 more
-
Poznań, PolandPoznan University of Life Sciences
Jul 7, 2022
Children and Adults With CTNNB1 Mutation
Completed
- CTNNB1 Gene Mutation
- The Modified Checklist for Autism in Toddlers, Revised with Follow-Up (M-CHAT-R/F)
- +15 more
-
Sydney, Australia
- +2 more
Nov 1, 2022
Leukemia, Relapsed, Myeloid Trial in Netherlands, Switzerland (MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123
Recruiting
- Leukemia
- +3 more
- MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123 and CD70)
-
Amsterdam, Netherlands
- +4 more
Jan 4, 2023
Hepatitis C Infection, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir)
Completed
- Hepatitis C Infection
- Hepatitis C Virus
- (no location specified)
Jul 28, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +2 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +2 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Infection
- Compensated Cirrhosis
- ABT-450/r/ABT-267, ABT-333
- Ribavirin (RBV)
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333)
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +4 more
- (no location specified)
Jul 29, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +4 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Virus (HCV) Infection Genotype 1
- ABT-450/r/ABT-267
- +2 more
-
Phoenix, Arizona
- +47 more
Jun 27, 2022
Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-450/r/ABT-267, ABT-333,
Completed
- Hepatitis C Virus Infection
- +3 more
- ABT-450/r/ABT-267
- +2 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- Ribavirin
- (no location specified)
Jul 8, 2021
Melanoma, Young Adult Trial in Salt Lake City (diagnostic test, other, device)
Completed
- Melanoma
- Young Adult
- MC1R Genetic Testing
- +2 more
-
Salt Lake City, UtahHuntsman Cancer Institute
Jul 9, 2021
Hepatitis C, Chronic Trial in United States (ombitasvir, paritaprevir/r, dasabuvir + ribavirin, ombitasvir, paritaprevir/r,
Completed
- Hepatitis C, Chronic
- ombitasvir, paritaprevir/r, dasabuvir + ribavirin
- ombitasvir, paritaprevir/r, dasabuvir
-
Irvine, California
- +3 more
Jan 21, 2021
Vitamin D Deficiency, Vitamin D Insufficiency Trial in Worldwide (Calcifediol 75mcg, Calcifediol 100mcg, Calcifediol 125mcg)
Active, not recruiting
- Vitamin D Deficiency
- Vitamin D Insufficiency
- Calcifediol 75mcg
- +3 more
-
Sevlievo, Bulgaria
- +54 more
May 2, 2022
Phenotype/Genotype Correlations in Movement Disorders
Recruiting
- Movement Disorder
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
ALS, FTD Trial in Worldwide (WVE-004, Placebo)
Active, not recruiting
- ALS
- FTD
- WVE-004
- Placebo
-
North Ryde, New South Wales, Australia
- +16 more
Feb 2, 2023
Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)
Not yet recruiting
- Recurrent Severe Aplastic Anemia
- Refractory Severe Aplastic Anemia
- Anti-Thymocyte Globulin
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 23, 2023
Early Alzheimer's Disease Trial in Worldwide (Experimental: ALZ-801, Placebo Comparator: Placebo)
Recruiting
- Early Alzheimer's Disease
- Experimental: ALZ-801
- Placebo Comparator: Placebo
-
Phoenix, Arizona
- +95 more
Aug 18, 2022
Hereditary Hemorrhagic Telangiectasia, HHT, Rendu Osler Weber Disease Trial in Madrid (Registry)
Recruiting
- Hereditary Hemorrhagic Telangiectasia
- +2 more
- Registry
-
Madrid, SpainHospital Universitario Ramón y Cajal
Sep 30, 2022